Natalie Pompilio


Making a Difference Face to Face and Across the Globe With Cancer Policy Efforts

January 7th 2021

As CEO of the American Society of Clinical Oncology, Clifford A. Hudis, MD, is always on the go—and not just between his home in New York and ASCO headquarters in Virginia.

NCCN Goes Global With Guidelines Tailored for Treatment Capabilities Abroad

May 20th 2019

The NCCN is working to develop modified guidelines for specific regions that offer less-costly and less–technologically intensive cancer treatment alternatives.

US Market Is Still Waiting for Biosimilars to Produce Meaningful Price Reductions

March 14th 2019

When the FDA approved its first biosimilar drug in 2015—filgrastim-sndz, for compromised white blood cell count—there was talk of the benefits of competition in the pharma industry; increased access to medications for patients; and, of course, the all-around savings. Four years later, those benefits haven’t been fully realized,

Heightened Risk for Natural Disasters Necessitates Advance Preparation in Oncology Community

February 5th 2019

With hugely destructive storms now almost routine—3 of the 5 costliest hurricanes on record occurred in 2017—the secret to practice readiness is constant review and analysis.

Specialization Trend Is Changing the Oncology Landscape

October 15th 2018

An increasing number of oncologists are choosing to specialize, affecting how patient care is delivered and the futures of small practices and large cancer clinics.

Practices Struggle With Oncology Care Model Report Cards

July 31st 2018

The Oncology Care Model is a patient-centric program that the Centers for Medicare & Medicaid Services says will allow for “better care, smarter spending, and healthier people.”